Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To Pete Lozano

Thank you for your reply.

With the ASM not now being held until 2011, it might be possible for your nomination to be included under the SEC 3% proposal. I make this as a "suggestion", as requested, and I'm sure others will be able to advise you if this is doable.

.

.

.

Be well

Share
New Message
Please login to post a reply